Recombinant Rat Armadillo repeat-containing protein 10 (Armc10)

What is Armadillo repeat-containing protein 10 (Armc10) and what are its key structural features?

Armc10 (also known as Armadillo repeat-containing protein 10) is a protein containing armadillo repeat domains. The full-length human ARMC10 consists of 306 amino acids, with high conservation among vertebrates . The protein contains multiple armadillo repeat domains that facilitate protein-protein interactions. The N-terminal region contains mitochondrial targeting sequences, while the armadillo repeat domains are crucial for interactions with other proteins involved in mitochondrial dynamics.

A key phosphorylation site at serine 45 (S45) has been identified as particularly important for ARMC10 function. This site lies within an AMPK consensus phosphorylation motif that is highly conserved across species, including rats . The conservation of this phosphorylation site suggests similar functional mechanisms across different mammalian species.

What are the primary cellular functions of Armc10?

Armc10 plays several important roles in cellular processes:

• Mitochondrial dynamics regulation - Armc10 is a critical regulator of mitochondrial fission. Overexpression of ARMC10 has been demonstrated to promote mitochondrial fission, while knockout of ARMC10 prevents AMPK-mediated mitochondrial fission .

• Cell survival and growth - Evidence suggests Armc10 may play roles in promoting cell survival and regulating cell growth .

• Transcriptional regulation - Armc10 may suppress the transcriptional activity of the tumor suppressor p53/TP53, suggesting a potential role in cell cycle regulation and response to cellular stress .

• Energy sensing pathway integration - As an AMPK substrate, Armc10 likely serves as an effector in energy homeostasis pathways, linking cellular energy status to mitochondrial dynamics .

These functions position Armc10 at the intersection of cellular energy metabolism and mitochondrial morphology regulation, making it relevant for research in metabolic disorders, neurodegenerative diseases, and cancer.

What expression systems are most effective for producing recombinant rat Armc10?

Multiple expression systems have been utilized for recombinant Armc10 production, each with specific advantages for different research applications:

For bacterial expression, recombinant Armc10 can be expressed with maltose-binding protein (MBP) tags to enhance solubility . For mammalian expression, systems utilizing Gateway-compatible destination vectors have been successfully employed to express N- or C-terminal-tagged fusion proteins . The choice of expression system should be guided by the specific research requirements, particularly whether post-translational modifications (such as phosphorylation at S45) are essential for the study.

What purification strategies yield the highest purity and activity for recombinant rat Armc10?

Effective purification of recombinant rat Armc10 typically employs affinity chromatography strategies based on fusion tags:

• For bacterial expression, MBP-tagged Armc10 can be purified using amylose resin affinity chromatography followed by size exclusion chromatography to remove aggregates .

• For mammalian expression systems, Strep-tagged Armc10 can be purified using one-step affinity chromatography with Strep-Tactin resins . This method has been reported to yield functional protein with preserved enzymatic activity.

To maintain protein stability and activity during purification:

• Include protease inhibitors in all buffers

• Maintain reduced temperatures (4°C) throughout the purification process

• Consider adding reducing agents (DTT or β-mercaptoethanol) to prevent disulfide bond formation

• Optimize buffer conditions (pH 7.5-8.0 and 150-300 mM NaCl) for stability

The final purified protein should be assessed for purity by SDS-PAGE and for functional activity through phosphorylation assays or mitochondrial fission assays as appropriate.

How can the AMPK-mediated phosphorylation of rat Armc10 be detected and quantified?

AMPK-mediated phosphorylation of Armc10 at serine 45 (S45) can be detected and quantified through several complementary approaches:

• In vitro kinase assays: Recombinant purified Armc10 (wild-type or S45A mutant) can be incubated with active recombinant AMPK and γ-32P-ATP in kinase buffer (25 mM Tris, pH 7.5, 5 mM β-glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3VO4, 10 mM MgCl2) at 30°C for 15 minutes. The reactions can be analyzed by SDS-PAGE followed by autoradiography to detect phosphorylation .

• Phospho-specific antibodies: Anti-ARMC10 S45 phospho-specific antibodies can be generated against KLH-conjugated phospho-peptide GIRSSK(phospho-S)AED. These antibodies should be pre-cleared with non-phosphopeptide and affinity-purified for specificity .

• Mass spectrometry: Phosphoproteomic analysis using liquid chromatography-tandem mass spectrometry (LC-MS/MS) can identify and quantify phosphorylation at S45. Both label-free quantification and SILAC approaches have successfully detected this phosphorylation event .

• Cellular assays: Treatment of cells with AMPK activators (e.g., AICAR, metformin, or A-769662) followed by immunoblotting with phospho-specific antibodies can demonstrate in vivo phosphorylation in response to AMPK activation.

The combination of these approaches provides robust validation of Armc10 phosphorylation and allows for quantitative assessment of this post-translational modification under various experimental conditions.

What methods are most reliable for studying Armc10's role in mitochondrial dynamics?

Several methodological approaches have proven effective for investigating Armc10's function in mitochondrial dynamics:

• Fluorescence microscopy techniques:

  • Confocal microscopy with mitochondrial staining (using MitoTracker dyes or antibodies against mitochondrial markers like TOM20)

  • Live-cell imaging to track dynamic changes in mitochondrial morphology

  • Super-resolution microscopy for detailed analysis of mitochondrial ultrastructure

• Genetic manipulation approaches:

  • CRISPR/Cas9-mediated knockout of Armc10

  • Expression of wild-type or mutant (S45A phospho-deficient) Armc10

  • siRNA-mediated knockdown for transient depletion

• Biochemical interaction studies:

  • Co-immunoprecipitation with mitochondrial fission proteins (MFF, FIS1, Drp1)

  • BioID proximity labeling to identify the interactome of Armc10

  • Pull-down assays with recombinant proteins to confirm direct interactions

• Quantitative analysis of mitochondrial morphology:

  • Morphometric analysis measuring mitochondrial length, area, and interconnectivity

  • Automated image analysis using software like ImageJ with appropriate plugins

  • Categorization of mitochondrial networks as fragmented, intermediate, or tubular

For robust experimental design, combine these approaches with appropriate controls:

• AMPK activators (e.g., AICAR) or inhibitors (e.g., Compound C)

• Mitochondrial fission inhibitors (e.g., mdivi-1)

• Expression of known mitochondrial dynamics regulators (e.g., Drp1, Mfn1/2)

What protein-protein interactions of Armc10 have been validated and how can they be studied?

Several key protein-protein interactions of Armc10 have been validated through multiple experimental approaches:

• Validated interaction partners:

  • Drp1 (DNM1L): A key mediator of mitochondrial fission that directly interacts with Armc10

  • MFF: Mitochondrial fission factor that facilitates Drp1 recruitment to mitochondria

  • FIS1: Mitochondrial fission protein that interacts with Armc10

  • AMPK: Phosphorylates Armc10 at S45

• Methods for studying these interactions:

  Method	Description	Best Application
  Co-immunoprecipitation	Pull-down with anti-Armc10 antibodies followed by western blotting for interaction partners	Verification of endogenous interactions
  BioID	Proximity-dependent biotinylation using BioID2-tagged Armc10 followed by streptavidin pulldown and mass spectrometry	Discovery of novel proximity interactions
  GST pulldown	Direct binding using purified recombinant proteins	Confirmation of direct interactions
  FRET/BRET	Fluorescence/bioluminescence resonance energy transfer between tagged proteins	Real-time monitoring of interactions in living cells
  Yeast two-hybrid	Screening for novel interaction partners	Initial discovery of potential interactors

• Studying interaction dynamics:

  • Analyze changes in interactions after AMPK activation

  • Compare wild-type versus S45A mutant Armc10 binding profiles

  • Examine interactions during different metabolic states or cellular stresses

The BioID technique has been particularly valuable for identifying the Armc10 interactome. In this approach, BioID2-tagged Armc10 is expressed in cells, allowing biotinylation of proximal proteins, which are then captured with streptavidin beads and identified by mass spectrometry .

How can phosphomimetic and phosphodeficient mutants of rat Armc10 be designed to study its regulation?

Strategic design of phosphomimetic and phosphodeficient mutants is crucial for dissecting the functional significance of Armc10 phosphorylation:

• Key sites for mutation:

  • S45A (phosphodeficient): Replacing serine with alanine prevents phosphorylation

  • S45D/E (phosphomimetic): Replacing serine with aspartic or glutamic acid mimics constitutive phosphorylation

  • Additional control: mutation of surrounding residues in the AMPK consensus motif

• Design considerations:

  • Ensure mutations don't disrupt protein folding or stability

  • Consider the exact local sequence context from rat Armc10

  • For advanced studies, generate double or triple mutants if multiple phosphorylation sites are identified

• Cloning strategy:

  • Use PCR-mediated site-directed mutagenesis to introduce specific mutations

  • Clone mutated sequences into Gateway-compatible vectors for versatile expression options

  • Consider using codon-optimized sequences for the expression system of choice

• Validation experiments:

  • Verify expression levels are comparable to wild-type protein

  • Confirm subcellular localization is preserved (mitochondrial targeting)

  • Test phosphorylation status using phospho-specific antibodies

  • Evaluate effects on protein-protein interactions with known partners (Drp1, MFF, FIS1)

• Functional assays for comparing mutants:

  • Mitochondrial morphology assessment

  • Response to AMPK activators or inhibitors

  • Cell survival under metabolic stress conditions

  • Protein interaction profile differences

These mutants provide powerful tools for dissecting the specific role of AMPK-mediated phosphorylation in regulating Armc10 function in mitochondrial dynamics and other cellular processes.

What are the best approaches for generating specific antibodies against rat Armc10?

Generating high-quality, specific antibodies against rat Armc10 requires careful strategy and validation:

• Antigen design options:

  • Full-length recombinant rat Armc10 protein

  • Synthetic peptides from unique regions of rat Armc10

  • Phospho-specific peptides for detecting phosphorylated S45

  • Considerations for cross-reactivity with mouse or human orthologs

• Production methods:

  • Traditional hybridoma technology using immunized rats (for mouse Armc10) or mice (for rat Armc10)

  • Recombinant antibody approaches using phage display

  • High-throughput cell-based ELISA for screening hybridoma supernatants

  • Cloning of variable regions into expression vectors for recombinant production

• Validation criteria:

  • Western blot against recombinant protein and endogenous Armc10

  • Immunoprecipitation efficiency

  • Immunofluorescence showing expected mitochondrial localization

  • Reduced/absent signal in knockout or knockdown cells

  • Cross-reactivity testing against related proteins

• Phospho-specific antibody production:

  • Generate using KLH-conjugated phospho-peptide (e.g., GIRSSK(phospho-S)AED)

  • Pre-clear with non-phosphopeptide to remove non-specific antibodies

  • Affinity purify using immobilized phosphopeptide

  • Validate with wild-type versus S45A mutant proteins

The rapid high-throughput selection approach described in the search results could be adapted for rat Armc10 antibody production, allowing efficient screening and selection of specific antibodies with desired characteristics.

How can CRISPR/Cas9 be utilized to study Armc10 function in rat cell lines or animal models?

CRISPR/Cas9 genome editing offers powerful approaches for studying Armc10 function in various experimental systems:

• Design of guide RNAs (gRNAs):

  • Target early exons of the rat Armc10 gene for efficient knockout

  • Use tools like CRISPOR or CHOPCHOP to design specific gRNAs with minimal off-target effects

  • Consider multiple gRNAs to increase editing efficiency

  • For knock-in applications, design repair templates with desired mutations (e.g., S45A)

• Delivery methods for rat cells:

  • Plasmid-based delivery of Cas9 and gRNA

  • Ribonucleoprotein (RNP) complex delivery for transient editing

  • Lentiviral vectors for stable integration in difficult-to-transfect cells

  • For in vivo editing in rats, consider adeno-associated viral (AAV) vectors

• Validation strategies:

  • PCR amplification and sequencing of the target region

  • Western blotting to confirm protein loss

  • Functional assays (mitochondrial morphology analysis)

  • Off-target analysis using whole-genome sequencing or targeted sequencing

• Advanced genome editing applications:

  • Knock-in of fluorescent tags for live imaging of endogenous Armc10

  • Introduction of specific mutations (S45A or S45D) at the endogenous locus

  • Conditional knockout systems using Cre-loxP or similar approaches

  • Tissue-specific editing in rat models

• Phenotypic analysis in knockout models:

  • Mitochondrial network morphology assessment

  • Response to metabolic stress conditions

  • AMPK pathway activation and signaling

  • Cell viability, growth, and metabolic profiling

The human codon-optimized Cas9 construct and target gRNA expression constructs mentioned in the search results could potentially be adapted for rat cell genome editing with appropriate modifications to target rat Armc10 sequences.

What are common pitfalls when working with recombinant rat Armc10 and how can they be addressed?

Researchers working with recombinant rat Armc10 may encounter several challenges:

• Protein solubility issues:

  • Challenge: Recombinant Armc10 may form insoluble aggregates during expression

  • Solution: Use solubility-enhancing tags (MBP, GST, SUMO), optimize expression temperature (16-18°C), or employ cell-free protein synthesis systems

• Post-translational modification heterogeneity:

  • Challenge: Inconsistent phosphorylation status affecting functional studies

  • Solution: Use phosphatase treatment to remove all phosphorylations or in vitro kinase reactions to ensure homogeneous phosphorylation; alternatively, use phosphomimetic mutants

• Mitochondrial localization concerns:

  • Challenge: Overexpressed tagged Armc10 may not properly localize to mitochondria

  • Solution: Verify localization using immunofluorescence with mitochondrial markers (TOM20, COX IV); ensure tags don't interfere with N-terminal mitochondrial targeting sequences

• Antibody cross-reactivity:

  • Challenge: Antibodies may cross-react with related armadillo repeat-containing proteins

  • Solution: Validate antibody specificity using knockout controls; use epitope-tagged versions for detection with tag-specific antibodies

• Functional assay variability:

  • Challenge: Inconsistent results in mitochondrial fission assays

  • Solution: Standardize cell culture conditions, control for cell density and passage number, include positive controls (known fission inducers like FCCP), and use automated quantification methods

How can contradictory results in Armc10 functional studies be reconciled and evaluated?

When faced with contradictory results in Armc10 research, systematic evaluation is essential:

• Methodological differences assessment:

  • Compare experimental conditions (cell types, expression levels, tags, assay timing)

  • Evaluate reagent differences (antibody specificity, protein constructs, purification methods)

  • Consider differences in quantification approaches and statistical analyses

• Biological context variations:

  • Metabolic state of cells (energy stress levels affect AMPK activation)

  • Cell cycle phase (mitochondrial dynamics change throughout the cell cycle)

  • Species differences between rat, mouse, and human Armc10 orthologs

  • Compensatory mechanisms in knockout models

• Reconciliation strategies:

  • Perform side-by-side comparisons under identical conditions

  • Use multiple complementary methodologies to test the same hypothesis

  • Collaborate with labs reporting different results to standardize protocols

  • Develop in vitro reconstitution systems to control all variables

• Reporting guidelines:

  • Document all experimental conditions meticulously

  • Report both positive and negative results

  • Share detailed protocols including buffer compositions and incubation times

  • Consider pre-registration of experimental plans to reduce bias

• Key parameters to control and report:

  • AMPK activation status (measured by T172 phosphorylation)

  • Armc10 expression levels (compared to endogenous)

  • Mitochondrial membrane potential during morphology assays

  • Exact cellular energy state (ATP/AMP ratios if possible)

By systematically addressing these factors, researchers can better understand the context-dependent roles of Armc10 and reconcile apparently contradictory findings in the literature.

What are the most promising approaches for studying the physiological roles of Armc10 in rat disease models?

Several approaches show particular promise for elucidating Armc10's physiological roles in disease contexts:

• Tissue-specific conditional knockout models:

  • Generate floxed Armc10 rat lines for tissue-specific deletion

  • Target tissues with high mitochondrial content (heart, brain, skeletal muscle)

  • Analyze metabolic phenotypes under normal and stressed conditions

  • Study disease progression in models of neurodegeneration, cardiac dysfunction, or metabolic disorders

• Physiological stress challenge paradigms:

  • Exercise testing to evaluate mitochondrial adaptation in skeletal muscle

  • Ischemia-reperfusion models to assess mitochondrial fragmentation responses

  • Caloric restriction or high-fat diet challenges to examine metabolic adaptation

  • Neurodegenerative disease models where mitochondrial dynamics are implicated

• Integrative multi-omics approaches:

  • Combine transcriptomics, proteomics, and metabolomics analyses

  • Correlate Armc10 phosphorylation status with global cellular responses

  • Map the complete Armc10 interactome under various physiological conditions

  • Identify metabolic signatures associated with Armc10 dysfunction

• Therapeutic targeting strategies:

  • Develop peptide inhibitors of specific Armc10 protein-protein interactions

  • Screen for small molecules that modulate Armc10-dependent mitochondrial fission

  • Test whether manipulating Armc10 function can protect against mitochondrial dysfunction

  • Explore the therapeutic potential of targeting Armc10 in metabolic or neurodegenerative diseases

These approaches provide complementary insights into Armc10's physiological roles and potential as a therapeutic target in disease contexts where mitochondrial dynamics are dysregulated.

What technological advances are needed to better understand Armc10's molecular mechanisms?

Several technological advances would significantly enhance our understanding of Armc10's molecular mechanisms:

• Structural biology advancements:

  • High-resolution crystal or cryo-EM structures of Armc10 alone and in complex with binding partners

  • Structural determination of phosphorylated versus non-phosphorylated states

  • NMR studies of dynamic conformational changes upon phosphorylation

  • Molecular dynamics simulations to predict functional impacts of modifications

• Advanced imaging technologies:

  • Super-resolution live-cell imaging to visualize Armc10 during mitochondrial fission events

  • Correlative light and electron microscopy to connect Armc10 localization with ultrastructural changes

  • Expansion microscopy for enhanced visualization of protein complexes at mitochondrial constriction sites

  • FRET/FLIM biosensors to detect Armc10 conformational changes in live cells

• Innovative proteomics approaches:

  • Proximity labeling techniques (BioID, APEX) to map the spatial organization of Armc10 complexes

  • Crosslinking mass spectrometry to identify direct binding interfaces

  • Single-cell proteomics to understand cell-to-cell variability in Armc10 function

  • Thermal proteome profiling to identify small molecule binders

• Functional genomics tools:

  • CRISPR screens to identify genetic modifiers of Armc10 function

  • Base editing or prime editing for precise genetic manipulation

  • Massively parallel reporter assays to study transcriptional regulation

  • Optogenetic or chemogenetic tools to achieve temporal control of Armc10 function

These technological advances would provide unprecedented insights into how Armc10 functions at the molecular level and how it integrates into broader cellular signaling networks regulating mitochondrial dynamics and energy homeostasis.

How does current knowledge about Armc10 integrate into broader understanding of mitochondrial dynamics regulation?

The identification of Armc10 as an AMPK substrate provides a crucial mechanistic link between cellular energy sensing and mitochondrial dynamics. Current evidence positions Armc10 as a key effector in the AMPK-mediated regulation of mitochondrial fission, with several important implications:

• Armc10 functions downstream of AMPK activation, likely serving as an adaptor that recruits or activates the core mitochondrial fission machinery including Drp1 .

• The direct interactions between Armc10 and fission proteins (MFF, FIS1, Drp1) suggest it functions as a scaffold that assembles the fission machinery at specific mitochondrial sites .

• This pathway represents a mechanism by which cells can rapidly adapt mitochondrial morphology in response to energy stress, providing a molecular basis for the observation that energy depletion often triggers mitochondrial fragmentation.

• The conservation of the AMPK phosphorylation site (S45) across species suggests this regulatory mechanism is evolutionarily conserved and functionally important .

Understanding Armc10's role complements existing knowledge about other AMPK substrates involved in mitochondrial regulation (such as MFF and ULK1), building a more comprehensive picture of how energy sensing pathways coordinate mitochondrial dynamics, quality control, and metabolic adaptation.

What consensus exists on best practices for experimental design when studying rat Armc10?

Based on the available literature, several consensus recommendations have emerged for robust experimental approaches when studying rat Armc10:

• Expression systems and purification:

  • Use both bacterial and mammalian expression systems depending on the research question

  • Include appropriate tags for purification (MBP, Strep) that don't interfere with function

  • Validate protein folding and activity after purification

• Functional characterization:

  • Combine in vitro biochemical assays with cellular studies

  • Use phospho-specific antibodies and phospho-mutants to study AMPK regulation

  • Perform rescue experiments in knockout backgrounds to confirm specificity

• Controls and validations:

  • Include both wild-type and S45A mutant versions in parallel experiments

  • Use AMPK activators (AICAR, A-769662) and inhibitors (Compound C) to manipulate the pathway

  • Validate antibody specificity using knockout or knockdown controls

• Mitochondrial dynamics assessment:

  • Standardize image acquisition and analysis parameters

  • Use multiple markers to assess mitochondrial morphology

  • Combine fixed-cell and live-cell imaging approaches

• Interaction studies:

  • Validate interactions using multiple complementary methods (co-IP, pulldown, BioID)

  • Study interactions under both basal and AMPK-activated conditions

  • Compare interaction profiles of wild-type and phospho-mutant versions